McSweeney L, Breckons M, Fattakhova G, Oluboyede Y, Vale L, Ternent L, Balp M-M, Doward L, Brass CA, Beyer F, Sanyal A, Anstee QM. Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosis. JHEP Rep. 2020 Mar 6;2(3). doi: 10.1016/j.jhepr.2020.100099
Raspa M, Sacco P, Candrilli SD, Bishop E, Petrillo J. Validity of a condition specific outcome measure for fragile X syndrome: the Aberrant Behaviour Checklist-utility index. J Intellect Disabil Res. 2016 Sep;60(9):844-55. doi: 10.1111/jir.12264
Beach RH, Poulos C, Pattanayak SK. Agricultural household response to avian influenza prevention and control policies. J Agr Appl Econ. 2007 Aug 1;39(2):301-11.
Rousu MC, Monchuk DC, Shogren JF, Kosa KM. Consumer willingness to pay for “second generation” genetically engineered products and the role of market information. J Agr Appl Econ. 2005 Dec;37(3):647-57. doi: 10.1017/S1074070800027140